229 related articles for article (PubMed ID: 22240402)
1. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
3. Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
Tolman JA; Wiederhold NP; McConville JT; Najvar LK; Bocanegra R; Peters JI; Coalson JJ; Graybill JR; Patterson TF; Williams RO
Antimicrob Agents Chemother; 2009 Jun; 53(6):2613-5. PubMed ID: 19289523
[TBL] [Abstract][Full Text] [Related]
4. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
10. Dose tolerability of chronically inhaled voriconazole solution in rodents.
Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.
Lewis RE; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2008 Nov; 52(11):4178-80. PubMed ID: 18725439
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Thors VS; Bierings MB; Melchers WJ; Verweij PE; Wolfs TF
Pediatr Infect Dis J; 2011 Mar; 30(3):268-70. PubMed ID: 21127455
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
14. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
Warn PA; Sharp A; Morrissey G; Denning DW
Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
[TBL] [Abstract][Full Text] [Related]
15. Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Beernaert LA; Pasmans F; Baert K; Van Waeyenberghe L; Chiers K; Haesebrouck F; Martel A
Vet Microbiol; 2009 Nov; 139(3-4):393-7. PubMed ID: 19574001
[TBL] [Abstract][Full Text] [Related]
16. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Chryssanthou E; Sjölin J
J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis.
Wiederhold NP; Najvar LK; Matsumoto S; Bocanegra RA; Herrera ML; Wickes BL; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2015 May; 59(5):2875-81. PubMed ID: 25753643
[TBL] [Abstract][Full Text] [Related]
18. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.
Lewis RE; Albert NP; Liao G; Wang W; Prince RA; Kontoyiannis DP
J Antimicrob Chemother; 2013 May; 68(5):1148-51. PubMed ID: 23349440
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.
Mihara T; Kakeya H; Izumikawa K; Obata Y; Nishino T; Takazono T; Kosai K; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Tsukamoto M; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S
J Infect Chemother; 2014 Feb; 20(2):104-8. PubMed ID: 24462443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]